We proudly donate 25% of our net profits to cancer research.
Transparency is incredibly important to us, and we want to make sure our customers are with us every step of the way. We officially opened on October 23, 2019 (welcome to our grand opening!), and made our first donation to the Liposarcoma Genome Project's campaign at Mass General Hospital on December 31, 2019.
The research that is coming out the SIMCHES research lab is extremely promising — not only for liposarcoma, but for all sarcoma types. Recent progress includes classifying the molecular profiles of and performing genomic microRNA analysis on both well-differentiated and dedifferentiated forms.
For more information or to donate, visit here: https://because.massgeneral.org/campaign/liposarcoma-genome-project/c109232
We're so happy to announce that the recipient of our next donations will be to the National Pediatric Cancer Foundation! We will be donating 25% of our net profits to the NPCF through September (Childhood Cancer Awareness Month) of this year! Learn more about our partnership here.
Our donations will be validated annually by a certified, independent third party and made public knowledge.
Want to recommend a foundation/research institution for us to consider?
We're always researching where to send our donations. We’re interested in partnering with large institutions and also smaller labs that are focused on hard-to-treat, rare cancers, such as diffuse intrinsic pontine glioma (DIPG) or rhabdomyosarcoma. Please contact us if you would like the partner with us or know an excellent cancer research institution or foundation we should consider.
Cancer research is a field rife with opportunity for historic breakthroughs that will alter the course of human health. We’re still in the infancy of our understanding of such a complex disease, but each year brings us closer to new developments that could have a global impact on an illness that affects one in three people.